In humans, AIF-1L is involved in inflammation responses triggered by pathogenic infection or tissue injury, and increased AIF1 expression has been linked to several diseases, including endometriosis, breast cancer, atherosclerosis, rheumatoid arthritis and fibrosis (review by [92]). This evidence concerns the gene AIF1L and breast carcinoma.